Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Goodwill & Intangibles: 2010-2024

Historic Goodwill & Intangibles for OptimizeRx (OPRX) over the last 15 years, with FY2024 value amounting to $76.4 million.

  • OptimizeRx's Goodwill & Intangibles fell 3576.51% to $75.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $75.9 million, marking a year-over-year decrease of 3576.51%. This contributed to the annual value of $76.4 million for FY2024, which is 4073.74% down from last year.
  • OptimizeRx's Goodwill & Intangibles amounted to $76.4 million in FY2024, which was down 4073.74% from $128.9 million recorded in FY2023.
  • OptimizeRx's Goodwill & Intangibles' 5-year high stood at $128.9 million during FY2023, with a 5-year trough of $31.9 million in FY2020.
  • In the last 5 years, OptimizeRx's Goodwill & Intangibles had a median value of $44.5 million in 2022 and averaged $62.8 million.
  • In the last 5 years, OptimizeRx's Goodwill & Intangibles skyrocketed by 18964.69% in 2023 and then crashed by 4073.74% in 2024.
  • OptimizeRx's Goodwill & Intangibles (Annual) stood at $31.9 million in 2020, then grew by 1.21% to $32.3 million in 2021, then soared by 37.97% to $44.5 million in 2022, then surged by 189.65% to $128.9 million in 2023, then tumbled by 40.74% to $76.4 million in 2024.
  • Its Goodwill & Intangibles was $76.4 million in FY2024, compared to $128.9 million in FY2023 and $44.5 million in FY2022.